| Financial Year |
March 31 2023 |
| Monetary Funds |
1,214,966,438.53 |
| Held-for-trading Financial Assets |
15,000,000.00 |
| Notes Receivable |
898,627.23 |
| Accounts Receivable |
1,077,309,368.97 |
| Advances to Suppliers |
142,199,471.50 |
| Other Receivables |
110,814,610.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
934,754,655.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,047,930.62 |
| Other Current Assets |
106,930,024.55 |
| Total Current Assets |
3,685,491,119.18 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,932,050.39 |
| Long-term Equity Investment |
671,382,882.73 |
| Investment Properties |
37,957,600.56 |
| Fixed Assetes |
1,370,453,291.97 |
| Under-construction Projects |
137,830,230.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
748,727,495.52 |
| R&D expenses |
2,604,377,750.67 |
| Goodwill |
2,737,766,723.37 |
| Long-Term Deferred and Prepaid Expenses |
46,117,473.37 |
| Deferred Income Tax Assets |
305,432,335.88 |
| Other Non-Current Assets |
140,122,521.14 |
| Sub-Total of Non-Current Assets |
8,903,371,123.13 |
| Total Assets |
12,588,862,242.31 |
| Short-Term Loans |
810,426,926.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
518,875.14 |
| Accounts Payable |
318,203,766.19 |
| Accounts Received In Advance |
375,294.87 |
| Employee Compensation Payable |
117,339,267.41 |
| Taxes Payable |
59,748,168.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
222,147,045.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
430,410,047.86 |
| Other Current Liabilities |
8,769,047.59 |
| Sub-Total of Current Liabilities |
2,080,493,985.27 |
| Long-term Loans |
995,414,464.31 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,003,034.53 |
| Deferred Income Tax Liabilities |
139,540,810.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,342,588,934.07 |
| Total Liabilities |
3,423,082,919.34 |
| Paid-In Capital(Or Share Stock) |
1,046,318,444.68 |
| Capital Surplus |
2,992,852,296.96 |
| Surplus Reserve |
150,075,000.00 |
| LESS:Treasury Stock |
121,005,048.45 |
| Undistributed Profits |
4,819,374,422.79 |
| Minority Stockholder's Interest |
306,300,079.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,859,479,243.18 |
| Owner's Equity（Stockholder's Equity） |
9,165,779,322.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,588,862,242.31 |
